Effect of aging and sex on the [3H]-paroxetine binding to human platelets

Journal of Affective Disorders

Volumn 50, Issue 1, 1998, Pages 11-15

  Marazziti, Donatella ^a   Rossi, Alessandra ^a   Palego, Lionella ^a   Barsanti, Antonella ^b   Carrai, Mario ^b   Giannaccini, Gino ^a   Serra, Paola ^a   Lucacchini, Antonio ^a   Cassano, Giovanni B ^a  

^a Dipartimento di Informatica   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

3H imipramine binding; 3H paroxetine binding; Aging; Human platelets; Serotonin; Serotonin transporter; Sex

Indexed keywords

IMIPRAMINE; PAROXETINE; SEROTONIN TRANSPORTER;

AGING; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; MEMBRANE BINDING; MOLECULAR CLONING; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEX DIFFERENCE; THROMBOCYTE ADHESION; THROMBOCYTE MEMBRANE;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PLATELETS; FEMALE; HUMANS; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

EID: 0031821004     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00074-8     Document Type: Article

References (30)

1. 3H-Paroxetine binding in human platelets in relation to age and sex. Neurobiol. Aging. 11:1990;615-618.
2. 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine. Life Sci. 52:1993;1767-1775.
3. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J.O. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res. 620:1993;163-166.
4. 3H-imipramine binding in human platelets: age and sex effects. Neuropsyhcobiology. 11:1984;178-180.
5. Demet E.M., Chicz-Demet A. Seasonal patterns in platelet ligand binding are related to membrane proteins. Biol. Psychiatry. 39:1996;430-435.
6. Ellis P.M., Salmond C. Is platelet imipramine binding reduced in depression? A meta-analysis. Biol. Psychiatry. 36:1994;292-299.
7. Graham D., Langer S.Z. Advances in sodium-ion coupled biogenic amine transporters. Life Sci. 51:1992;631-645.
8. Halbreich U., Rojansky N., Zander K.J., Barkai A. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J. Psychiat. Res. 25:1991;7-18.
9. Hoffman B.J., Mezey E., Brownstein M.J. Cloning of a serotonin transporter affected by antidepressants. Science. 254:1991;579-580.
10. 3H-imipramine binding in intact human platelets. Biol. Psychiatry. 25:1989;576-584.
11. 3H-imipramine binding sites. Eur. J. Pharmacol. 106:1985;669-672.
12. 3H-imipramine binding in human platelets: influence of age and sex. Naunyn Schmiedeberg's Arch. Pharmacol. 313:1980;189-194.
13. 3H-paroxetine binding, a marker of serotonin uptake sites. Biol. Psychiatry. 24:1988;299-309.
14. Lesch, K.P., Wolozin, B.L., Murphy, D.L., Riederer, 1993. Primary structure of the human platelet serotonin uptake: identity with the brain serotonin transporter. J. Neurochem. 60, 2319-2322.
15. 3H-imipramine receptors: Effect of age. Int. J. Clin. Pharmacol. Res. VII(2):1987;145-148.
16. 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology. 34:1996;184-4187.
17. 3H-imipramine to protease-sensitive and protease-resistant sites. J. Neurochem. 44:1985;705-711.
18. Marcusson J.O., Baeckstroem I., Ross S.B. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine binding site. Mol Pharmacol. 30:1986;121-128.
19. Marcusson J.O., Ross S.B. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology. 102:1991;145-155.
20. Mc Pherson, G.A., Kinetic, EBDA, LIGAND, 1985. Lowry: a collection of radioligand binding analysis programs. Biosoft, Cambridge, UK.
21. 3H-imipramine to human platelet membranes. Eur. J. Pharmacol. 96:1983;303-309.
22. 3H-imipramine and the serotonin transporter in human platelets. J. Neurochem. 48:1987;560-565.
23. Nie, N.H., Hull, C.H., Steinbrenner, K., Bent, D.H., 1975. Statistical Package for the Social Sciences (SPSS), 2nd edition. McGraw-Hill Company, New York.
24. Owens, M.J., Nemeroff, C.B., 1994. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin. Chem. 40/2, 288-295.
25. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc. Natl. Acad. Sci. USA. 90:1993;2542-2546.
26. Rausch J.J., Hutchinson J., Li X. Correlations of drug action between human platelets and human brain 5HTT. Biol. Psychiatry (suppl.). 137:1995;600.
27. 3H-imipramine binding by serotonin and non-tricyclic serotonin uptake blockers. J. Neurochem. 40:1987;622-628.
28. 3H-imipramine binding based on ion dependence and serotonin sensitivity. J. Neurochem. 46:1986;1743-1754.
29. Stahl S.M. The human platelets. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurological disorders. Arch. Gen. Psychiatry. 34:1977;509-516.
30. Wennogle L.P., Meyerson L.R. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes. Eur. J. Pharmacol. 86:1985;303-307.